Medtronic Set To Compete With Abbott/St Jude In VADs After Buying HeartWare
This article was originally published in Clinica
Executive Summary
HeartWare has found a way to pay for the expanded commercialization of its HVAD ventricular assist device and the development of its MVAD miniaturized ventricular assist device; the Boston-area VAD-maker has agreed be acquired by medtech giant Medtronic for $1.1bn in cash.